Latest Breaking News On - தடுப்பூசி மருத்துவ ஆராய்ச்சி - Page 1 : comparemela.com

Pfizer COVID-19 Vaccine Could Be Available For Ages 2 & Up By Fall Data from Pfizer s coronavirus vaccine trials in children aged 2 years and older could be available as early as this fall, Pfizer s Senior Vice President of Vaccine Clinical Research and Development Dr. William Gruber said, possibly paving the way for use before the end of 2022. The drugmaker is also conducting clinical trials on their vaccine for babies aged 6 months and older. Gruber anticipates data from those trials will likely be available late at the end of the year or beginning of 2022. Speaking on CBS This Morning just a day after the Food and Drug Administration granted Pfizer emergency use authorization for its COVID-19 vaccine in children aged 12 to 15, Gruber called the move a major step toward herd immunity in the United States. 

United-states
Americans
William-gruber
Pfizer
Drug-administration
Development-dr
Vaccine-clinical-research
Senior-vice-president
ஒன்றுபட்டது-மாநிலங்களில்
அமெரிக்கர்கள்
வில்லியம்-க்ரூபர்
ஃபைசர்